Disassembly of Prion Protein Fragment 106‐126 Aggregates Driven by an Organopalladium‐Modified Polyoxometalate
Small · 2025
DOI: 10.1002/smll.202507590 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Yanfei Lv und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, Beijing, 100029, China. Hauptthemen laut MEDLINE: Tungsten Compounds, Prion Proteins, Palladium, Protein Aggregates. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Beijing Natural Science Foundation, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Prion disorders are characterized by the pathological misfolding of cellular prion proteins into the infectious and aggregated isoforms (PrP Sc ). Due to the dynamic folding‐unfolding equilibrium of prion protein, therapeutic strategies targeting PrP Sc often suffer from reversible binding and incomplete efficacy. Herein, an organopalladium‐modified polyoxometalate (Pd‐MnMo 6 ) is synthesized by covalently grafting [Pd(tpy)Cl] onto Mn‐Anderson (denoted as MnMo 6 ). The Pd‐MnMo 6 effectively disassembles 92.8% of preformed PrP106‐126 fibrils and exhibits significant cytoprotection effect in SH‐SY5Y cells. This protection effect is evidenced by the attenuation of PrP106‐126 aggregates‐induced cytotoxicity, suppression of excessive reactive oxygen species production, and mitigation of mitochondrial membrane depolarization. Mechanism studies reveal that Pd‐MnMo 6 interacts with PrP106‐126 through multiple interaction modes: electrostatic interaction, hydrogen bonding, π – π stacking and metal coordination. Analysis of the dynamic binding between Pd‐MnMo 6 and a PrP106‐126 decamer reveals that electrostatic attraction drives the initial approach of Pd‐MnMo 6 to the PrP106‐126 N‐terminus, enabling subsequent π – π stacking (between the tpy ligand and histidine residues) and Pd coordination to methionine sites. This synergistic interaction network disrupts the dynamic folding equilibrium of PrP106‐126, leading to irreversible binding and effective disassembly of PrP106‐126 aggregates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, Beijing, 100029, China.
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking, Union Medical College, Beijing, 100021, China.
ORCID-Profile: Lei He, Yu-Fei Song
Förderung
- Beijing Natural Science Foundation
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Lv, Y., Zhang, C., Fu, Y., Wu, Z., Li, B., Xu, X., Guo, Y., He, L., & Song, Y. F. (2025). Disassembly of Prion Protein Fragment 106‐126 Aggregates Driven by an Organopalladium‐Modified Polyoxometalate. Small. https://doi.org/10.1002/smll.202507590
Vancouver
Lv Y, Zhang C, Fu Y, Wu Z, Li B, Xu X, et al. Disassembly of Prion Protein Fragment 106‐126 Aggregates Driven by an Organopalladium‐Modified Polyoxometalate. Small. 2025. doi:10.1002/smll.202507590
BibTeX
@article{Lv2025,
author = {Lv, Yanfei and Zhang, Chenxi and Fu, Yuxia and Wu, Zhaohui and Li, Bole and Xu, Xiaotong and Guo, Yunfei and He, Lei and Song, Yu-Fei},
title = {Disassembly of Prion Protein Fragment 106‐126 Aggregates Driven by an Organopalladium‐Modified Polyoxometalate},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202507590}
}
EUVIMED